Overview
Kin Lam is an Oncologist practicing medicine in New York, New York.
Dr. Lam is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Thalassemia, Malignant Peripheral Nerve Sheath Tumor, Myelodysplastic Syndrome (MDS), and Febrile Neutropenia.
He is actively involved in clinical research, co-authoring 1 peer reviewed article.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
139 Centre St Ste 515, New York, NY 10013
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Alison Moskowitz is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Moskowitz is highly rated in 33 conditions, according to our data. Her clinical expertise encompasses T-Cell Lymphoma, Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Moskowitz is currently accepting new patients.
Rockefeller Outpatient Pavilion
William Tap is an Oncologist practicing medicine in New York, New York. Dr. Tap is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Gastrointestinal Stromal Tumor, Angiosarcoma, Tissue Biopsy, and Liver Embolization. Dr. Tap is currently accepting new patients.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Steven Horwitz is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Horwitz is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, and Bone Marrow Aspiration. Dr. Horwitz is currently accepting new patients.
Frequently Asked Questions about Dr. Kin Lam
How do I make an appointment with Dr. Kin Lam?
You can book an appointment with Dr. Kin Lam by calling their office at 212-941-9020. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Kin Lam a top-rated expert for Thalassemia?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kin Lam is classified as an Distinguished expert for Thalassemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Kin Lam specialize in?
While Dr. Kin Lam is a Oncology, they have specific expertise in Thalassemia, Malignant Peripheral Nerve Sheath Tumor, and Myelodysplastic Syndrome (MDS). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Kin Lam participate in research or clinical trials?
Yes. Dr. Kin Lam has published 1 articles and abstracts on conditions like Thalassemia. You can view a list of Dr. Kin Lam's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Kin Lam accept my insurance?
Dr. Kin Lam accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 212-941-9020 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Malignant Peripheral Nerve Sheath Tumor
- ThalassemiaDr. Lam isDistinguished. Learn about Thalassemia.
- Advanced
- AgranulocytosisDr. Lam isAdvanced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
- Alpha ThalassemiaDr. Lam isAdvanced. Learn about Alpha Thalassemia.
- Alpha Thalassemia X-Linked Intellectual Disability Syndrome
- AnemiaDr. Lam isAdvanced. Learn about Anemia.
- AngiosarcomaDr. Lam isAdvanced. Learn about Angiosarcoma.
- Experienced
- Acute Eosinophilic PneumoniaDr. Lam isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Mountain SicknessDr. Lam isExperienced. Learn about Acute Mountain Sickness.
- AngiomyomaDr. Lam isExperienced. Learn about Angiomyoma.
- Arterial InsufficiencyDr. Lam isExperienced. Learn about Arterial Insufficiency.
- Autoerythrocyte SensitivityDr. Lam isExperienced. Learn about Autoerythrocyte Sensitivity.
- B-Cell LymphomaDr. Lam isExperienced. Learn about B-Cell Lymphoma.